Karen S. Anderson, Ph.D., Professor of Pharmacology, has been awarded a one-year, $413,750 high-priority bridge grant from the National Institute of Allergy & Infectious Diseases. Her project, entitled, “Exploring Novel Targeting Strategies for AIDS Protozoal Pathogens,” has been funded through the American Recovery and Reinvestment Act of 2009.
Karen S. Anderson, Ph.D., Professor of Pharmacology, has been awarded a one-year, $413,750 high-priority bridge grant from the National Institute of Allergy & Infectious Diseases. Her project, entitle
July 01, 2009